Breaking

[Maclear Study] European Investors Are Turning to P2P Lending: The Rise from Niche to Mainstream

Maclear’s recent research highlights why yield and trust are driving the growth of SME financing

P2P lending in Europe is shifting from a niche option for risk-tolerant investors to a recognized alternative within the wider financial market. A new study by Maclear shows that the sector is gaining momentum as investors look for higher yields and stronger safeguards, while small and medium-sized enterprises (SMEs) turn to crowdlending for more flexible access to capital.

According to the study, European investors are rethinking their strategies after years of limited choices. Traditional instruments still deliver only modest returns, while speculative markets remain volatile and unpredictable. In this context, P2P lending is emerging as a balanced alternative and a credible investment option.

The model is simple: platforms connect investors directly with SMEs, giving businesses access to funding and investors higher, more predictable returns. Yields remain the main driver — 93% of respondents consider projects above 12% ROI worth the risk, and more than half of investors target >15%. The market is also shaped by experienced participants, with three out of four investors active for more than a year.

The sector has primarily attracted experienced investors, but accessibility is expanding as platforms implement clearer safeguards and greater transparency.

Crowdlending has long been shaped by experienced investors who were willing to navigate limited regulation and transparency. Today, the sector has evolved: with collateral-backed models, stronger safeguards, and clearer processes, it is opening up to a wider group of participants and is set to become one of the key alternative investment trends of the next decade,” says Alexander Lang, CFO & Co-Founder of Maclear AG.

More findings are in the full report — visit the following link.

Boilerplate (about the company):

Maclear is a Swiss crowdlending platform that enables investors to fund real-world business projects and earn fixed annual returns of up to 15%. Since its launch in 2021, Maclear has facilitated over €30.7 million in funding, with more than €5.9 million already repaid, while maintaining a zero-default record.

Trusted by over 12,700 investors across 13 countries, the platform offers reliable, transparent, and accessible investment opportunities. With over 130 projects funded and a recent expansion into the UAE, Maclear continues to expand its global footprint, with top activity in Bulgaria, Estonia, and Italy

Joseph Wilson

Joseph Wilson is a veteran journalist with a keen interest in covering the dynamic worlds of technology, business, and entrepreneurship.

Recent Posts

Diagnostic Orders Direct Launches Affordable $40 Virtual Diagnostic Order Consultations Across 30 States

Affordable telehealth service helps patients request provider review for MRI, CT, X-ray, ultrasound, EKG, blood…

18 hours ago

TempraMed Featured on Dr. Phil Show in National US Broadcast Highlighting the Risk of Temperature Exposure for Insulin and Other Medications

Broadcast across the United States brings attention to the under-addressed risk of medication degradation caused…

18 hours ago

Jeffrey W. Meshel’sNew Book, Know Who You Know,Reveals Why the Right Relationships Shape Opportunity, Trust, and Destiny

NEW YORK, NEW YORK — At a time when networking has become increasingly shallow, automated,…

18 hours ago

General Tensor and Talisman Wallet Partner to Make Bittensor Effortless for Humans and the Agent Economy

Unlocking institutional capital for Bittensor. Pairing institutional wallet infrastructure and multi-sig tooling with one of…

18 hours ago

From Dakar Machines to Classic Legends: Motul 300V Delivers at Simola 2026

The 2026 Simola Hillclimb, held in Knysna from 1–3 May, once again proved to be…

18 hours ago

OhhMed Medical Launches UK Clinical Trial Evaluating Vertica Device Following Radical Prostatectomy

TIBERIAS, Israel -- OhhMed Medical Ltd., a leading medical technology company focused on male urology,…

18 hours ago

This website uses cookies.